Cwm, LLC Bluebird Bio, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,975 shares of BLUE stock, worth $730. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,975

Previous 8,910 77.83%

Holding current value

$730

Previous $9,000 88.89%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$0.47 - $1.35 $3,259 - $9,362	-6,935 Reduced 77.83%	1,975 $1,000
Q2 2024 Jul 09, 2024	BUY	$0.85 - $1.26 $7,301 - $10,823	8,590 Added 2684.38%	8,910 $9,000
Q1 2024 Apr 05, 2024	BUY	$0.91 - $1.75 $18 - $35	20 Added 6.67%	320 $0
Q4 2023 Feb 01, 2024	BUY	$1.32 - $4.83 $396 - $1,449	300 New	300 $0
Q1 2023 Apr 28, 2023	SELL	$3.14 - $8.22 $2,358 - $6,173	-751 Reduced 88.25%	100 $0
Q4 2022 Feb 01, 2023	BUY	$5.77 - $8.49 $242 - $356	42 Added 5.19%	851 $6,000
Q3 2022 Oct 27, 2022	SELL	$3.75 - $7.39 $71 - $140	-19 Reduced 2.29%	809 $5,000
Q2 2022 Jul 28, 2022	BUY	$2.94 - $5.23 $902 - $1,605	307 Added 58.93%	828 $3,000
Q1 2022 Apr 21, 2022	BUY	$4.07 - $10.6 $1,990 - $5,183	489 Added 1528.13%	521 $3,000
Q4 2021 Jan 31, 2022	SELL	$8.96 - $16.31 $2,177 - $3,963	-243 Reduced 88.36%	32 $0
Q4 2020 Sep 15, 2021	SELL	$27.5 - $37.92 $495 - $682	-18 Reduced 6.14%	275 $9,000
Q4 2020 Jan 27, 2021	BUY	$27.5 - $37.92 $495 - $682	18 Added 6.55%	293 $13,000
Q3 2020 Sep 15, 2021	SELL	$34.44 - $43.75 $619 - $787	-18 Reduced 6.14%	275 $9,000
Q3 2020 Oct 19, 2020	BUY	$34.44 - $43.75 $619 - $787	18 Added 6.55%	293 $16,000
Q2 2020 Sep 15, 2021	SELL	$27.12 - $45.97 $488 - $827	-18 Reduced 6.14%	275 $9,000
Q2 2020 Jul 22, 2020	BUY	$27.12 - $45.97 $488 - $827	18 Added 6.55%	293 $18,000
Q1 2020 Sep 15, 2021	BUY	$26.16 - $63.5 $497 - $1,206	19 Added 7.42%	275 $9,000
Q1 2020 Apr 28, 2020	SELL	$26.16 - $63.5 $497 - $1,206	-19 Reduced 6.91%	256 $12,000
Q4 2019 Sep 14, 2021	BUY	$46.96 - $61.67 $12,914 - $16,959	275 New	275 $9,000
Q4 2019 Jan 27, 2020	SELL	$46.96 - $61.67 $12,914 - $16,959	-275 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$59.47 - $93.1 $16,354 - $25,602	275 New	275 $9,000
Q3 2019 Oct 22, 2019	SELL	$59.47 - $93.1 $16,354 - $25,602	-275 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$75.84 - $105.21 $20,856 - $28,932	275 New	275 $9,000
Q2 2019 Jul 31, 2019	SELL	$75.84 - $105.21 $20,856 - $28,932	-275 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$64.44 - $104.11 $17,592 - $28,422	273 Added 13650.0%	275 $0
Q1 2019 Apr 22, 2019	SELL	$64.44 - $104.11 $1,933 - $3,123	-30 Reduced 93.75%	2 $0
Q3 2017 Oct 16, 2017	BUY	$57.74 - $91.42 $1,847 - $2,925	32	32 $4,000

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account